Abbott Laboratories (ABT) Interest Expenses (2009 - 2026)

Abbott Laboratories has disclosed Interest Expenses across 18 years of filings, most recently posting $351.0 million for Q2 2026.

• In Q2 2026, Interest Expenses rose 190.08% year-over-year to $351.0 million; the TTM figure through Jun 2026 stood at $766.0 million (up 44.53% YoY), while the FY2025 annual figure was $493.0 million, down 11.81% from the prior year.
• Interest Expenses came in at $351.0 million for Q2 2026 at Abbott Laboratories, up from $174.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $351.0 million in Q2 2026 to a low of $120.0 million in Q4 2025.
• Average Interest Expenses over 5 years is $154.0 million, with a median of $141.0 million recorded in 2022.
• Year-over-year, Interest Expenses slipped 14.79% in 2025 and surged 190.08% in 2026.
• Over 5 years, Interest Expenses stood at $154.0 million in 2022, then advanced by 3.25% to $159.0 million in 2023, then retreated by 14.47% to $136.0 million in 2024, then decreased by 11.76% to $120.0 million in 2025, then soared by 192.5% to $351.0 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $351.0 million in Q2 2026, $174.0 million in Q1 2026, and $120.0 million in Q4 2025.